Isonitroso-ethylisopropylketon | 122256-35-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: Isonitroso-ethylisopropylketon
• 英文别名: 4-methyl-pentane-2,3-dione-2-oxime；(2E)-2-hydroxyimino-4-methylpentan-3-one
• CAS: 122256-35-3
• 化学式: C₆H₁₁NO₂
• 分子量: 129.159
• InChiKey: SNAKZQGNQQFDCV-FNORWQNLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  49.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  Isonitroso-ethylisopropylketon 、 盐酸 生成 4-methyl-pentane-2,3-dione 3-(E)-oxime
  参考文献：
  名称：

  BARTNIK R.; ORLOWSKA B., POL. J. CHEM., 1980, 54, NO 7-8, 1603-1606,

  摘要：

  DOI：
• 作为产物：
  描述：

  2-甲基-3-戊酮 在 三甲基氯硅烷 、 亚硝酸异戊酯 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 生成 Isonitroso-ethylisopropylketon
  参考文献：
  名称：

  肟酯的光催化CC键活化用于酰基自由基的产生和应用

  摘要：

  据报道，有一种通过选择性C–C键活化从肟酯生成酰基的统一策略。在可见光照射下，发生了从fac -Ir（ppy）3到相关肟的单电子转移，接着是快速的C-C键β片段产生芳基和脂族酰基基团，随后被各种Michael受体捕获。更有趣的是，单电子转移能够通过就地形成环丁烷的烯酮中间体与激发的fac -Ir（ppy）3的能量转移耦合。

  DOI：

  10.1021/acs.orglett.9b01338

文献信息

• Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
  申请人：Glombik Heiner

  公开号：US20050267177A1

  公开（公告）日：2005-12-01

  Diarylcycloalkyl derivatives and their physiologically acceptable salts and physiologically functional derivatives are disclosed. The compounds include those of formula I, in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds typically have lipid- and/or triglyceride-lowering properties and are suitable, for example, for the treatment of disorders of lipid metabolism, of type II diabetes, and of syndrome X.

  公开了二芳基环烷基衍生物及其生理上可接受的盐和生理功能衍生物。这些化合物包括式I的那些，其中基团如所定义的，并公开了它们的生理上可接受的盐和制备过程。这些化合物通常具有降脂和/或三酸甘油酯降低性，并且适用于治疗脂质代谢紊乱、II型糖尿病和X综合征等疾病。
• Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals
  申请人：Stapper Christian

  公开号：US20050215596A1

  公开（公告）日：2005-09-29

  Provided herein are cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals

  本文提供了环烷基取代的氨基酸衍生物，其制备过程以及作为药物的用途。
• METHOD FOR THE PREPARATION OF OXAZOLES BY CONDENSING AROMATIC ALDEHYDES WITH ALPHA-KETOXIMES TO FORM N-OXIDES AND REACTING SAME WITH ACTIVATIVED ACID DERIVATIVES
  申请人：HOLLA Wolfgang

  公开号：US20080058529A1

  公开（公告）日：2008-03-06

  The present invention is comprised of improved methods in the preparation of oxazoles which results in higher yields with less impurities and contaminants. Oxazoles constitute valuable intermediates in the synthesis of pharmaceutically active substances such as, for example peroxisome proliferator activated receptor (PPAR) agonists which are pharmaceutical actives which can have a positive influence on both lipid and glucose metabolism.

  本发明涉及改进的制备噁唑的方法，其结果是产量更高，杂质和污染物更少。噁唑是合成药物活性物质的有价值的中间体，例如过氧化物酶体增殖物激活受体（PPAR）激动剂，这些药物活性物质可以对脂质和葡萄糖代谢产生积极影响。
• NOVEL INTERMEDIATE COMPOUNDS USEFUL IN THE PREPARATION OF OXAZOLES AND PHARMACEUTICAL ACTIVES FOR THE REGULATION OF LIPID AND GLUCOSE METABOLISM
  申请人：HOLLA Wolfgang

  公开号：US20080114035A1

  公开（公告）日：2008-05-15

  The present invention is directed to compounds of Formula III wherein the R1-R7 groups or substituents are defined herein. The present invention also comprises improved methods in the preparation of oxazoles in which the compounds of Formula III are intermediates and which results in higher yields with less impurities and contaminants. Oxazoles constitute valuable intermediates in the synthesis of pharmaceutically active substances such as, for example peroxisome proliferator activated receptor (PPAR) agonists which are pharmaceutical actives which can have a positive influence on both lipid and glucose metabolism.

  本发明涉及式III的化合物，其中R1-R7基团或取代基如本文所定义。本发明还包括改进的制备噁唑的方法，其中式III的化合物是中间体，并且可以获得更高的收率，同时减少杂质和污染物。噁唑是合成药物活性物质的有价值中间体，例如过氧化物酶体增殖物激活受体（PPAR）激动剂，这是一种药物活性物质，可以对脂质和葡萄糖代谢产生积极影响。
• METHOD FOR THE PRODUCTION OF OXAZOLES BY CONDENSING AROMATIC ALDEHYDES WITH a-KETOXIMES TO N-OXIDES AND THEN REACTING THE SAME WITH ACTIVATED ACID DERIVATIVES
  申请人：HOLLA Wolfgang

  公开号：US20090286988A1

  公开（公告）日：2009-11-19

  The invention is related to a process for preparing compounds of the formula IV by means of conversion of aromatic aldehydes of the formula I using α-ketoximes of the formula II via N-oxides of the formula III to halomethyloxazoles of the formula IV, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , X 1 , X 2 , X 3 , o, n1 and n2 are as defined herein.

  本发明涉及一种制备式IV化合物的方法，该方法通过使用式I的芳香醛，使用式II的α-酮肟经过式III的N-氧化物转化为式IV的卤代甲氧噁唑。其中，R1、R2、R3、R4、R5、R6、R7、R8、X1、X2、X3、o、n1和n2的定义如本文所述。